1. An early relook identifies high-risk trajectories in ambulatory advanced heart failure
- Author
-
Michelle M. Kittleson, Amrut V. Ambardekar, Lynne W. Stevenson, Nisha A. Gilotra, Palak Shah, Gregory A. Ewald, Jennifer T. Thibodeau, Josef Stehlik, Maryse Palardy, Jerry D. Estep, Thomas M. Cascino, J. Timothy Baldwin, Neal Jeffries, Shokoufeh Khalatbari, Matheos Yosef, Wendy Taddei Peters, Blair Richards, Douglas L. Mann, Keith D. Aaronson, and Garrick C. Stewart
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,Risk Assessment ,Severity of Illness Index ,Article ,Quality of life ,medicine ,Clinical endpoint ,Humans ,Prospective Studies ,Registries ,education ,Aged ,Heart Failure ,Heart transplantation ,Transplantation ,education.field_of_study ,business.industry ,Hazard ratio ,Middle Aged ,medicine.disease ,Triage ,Heart failure ,Ambulatory ,Emergency medicine ,Female ,Surgery ,Heart-Assist Devices ,Cardiology and Cardiovascular Medicine ,business - Abstract
Introduction Patients with ambulatory advanced heart failure (HF) are increasingly considered for durable mechanical circulatory support (MCS) and heart transplantation and their effective triage requires careful assessment of the clinical trajectory. Methods REVIVAL, a prospective, observational study, enrolled 400 ambulatory advanced HF patients from 21 MCS/transplant centers in 2015-2016. Study design included a clinical re-assessment of Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile within 120 days after enrollment. The prognostic impact of a worsening INTERMACS Profile assigned by the treating physician was assessed at 1 year after the Early Relook. Results Early Relook was done in 325 of 400 patients (81%), of whom 24% had a worsened INTERMACS Profile, associated with longer HF history and worse baseline INTERMACS profile, but no difference in baseline LVEF (median 0.20), 6-minute walk, quality of life, or other baseline parameters. Early worsening predicted higher rate of the combined primary endpoint of death, urgent MCS, or urgent transplant by 1 year after Early Relook, (28% vs 15%), with hazard ratio 2.2 (95% CI 1.2- 3.8; p = .006) even after adjusting for baseline INTERMACS Profile and Seattle HF Model score. Deterioration to urgent MCS occurred in 14% vs 5% (p = .006) during the year after Early Relook. Conclusions Early Relook identifies worsening of INTERMACS Profile in a significant population of ambulatory advanced HF, who had worse outcomes over the subsequent year. Early reassessment of ambulatory advanced HF patients should be performed to better define the trajectory of illness and inform triage to advanced therapies.
- Published
- 2022